Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp expected to post a loss of 43 cents a share - Earnings Preview

* Pulmonx Corp  LUNG.OQ   LUNG.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The Redwood City California-based  company is expected to
report
 a 21.4% increase in revenue to $16.386 million from $13.5
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. The company's guidance on
October 10 2023, for the period ended September 30, was for
revenue of $17.600 million.
    * ​Refinitiv's mean analyst estimate for Pulmonx Corp is for
a
loss of 43 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$16.5​, above​ its last closing price of $8.22. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.44       -0.44      -0.43     Beat    1.6
 Mar. 31 2023  -0.44       -0.44      -0.42     Beat    4.5
 Dec. 31 2022  -0.43       -0.42      -0.38     Beat    8.7​
 Sep. 30 2022  -0.40       -0.40      -0.38     Beat    4.2
 ​​Jun.        -0.42       -0.41      -0.40     Beat    2.4
 30 2022                                                
 Mar. 31 2022  -0.38       -0.37      -0.43     Missed  -15.9​
 Dec. 31 2021  -0.36       -0.36      -0.35     Beat    2.9
 Sep. 30 2021  -0.37       -0.37      -0.28     Beat    24.8
 This summary was machine generated October 28 at 01:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Pulmonx

See all news